Price (delayed)
$75.64
Market cap
$234.51B
P/E Ratio
36.9
Dividend/share
$1.45
EPS
$2.05
Enterprise value
$261.22B
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.